Readmissions due to acute biliary edematous pancreatitis in patients without cholecystectomy

Rev Esp Enferm Dig. 2016 Aug;108(8):473-8. doi: 10.17235/reed.2016.4067/2015.

Abstract

Aims: Analyzing the readmission of patients with acute biliary edematous pancreatitis (ABEP) without cholecystectomy despite a previous episode of mild acute gallstone pancreatitis or lithiasic cholecystitis. Calculating the health costs associated with the non-performance of cholecystectomy.

Material and methods: Prospective observational study conducted at a tertiary hospital from July to November 2014. The study has consecutively included inpatients suffering from ABEP who: a) had suffered a previous episode of mild acute gallstone pancreatitis or cholecystitis at least 2 weeks before readmission; and b) had not undergone cholecystectomy despite the lack of contraindications.

Results: During the research period, 9 patients (7 females and 2 males) with a mean age of 65.3 years (standard deviation [SD] 19.2) were readmitted. The median number of days between the previous episode of ABEP or cholecystitis and the readmission was 114 days (interquartile range [IQR] 111.0). Reported median overall length of hospital stay was 10 days (IQR = 2.0). Patients underwent a mean of 2.8 (SD = 1.2) ultrasound scans, 1.3 (SD = 0.9) abdominal and pelvic CT, 0.8 (SD = 1.0) MRCP and 0.2 (SD = 0.4) ERCP. The mean cost per patient for each readmission, including hospital stay (143.0 €/day), Emergency Service (332.31 €) and tests performed was 2,381.70 €/patient.

Conclusions: Not performing a cholecystectomy within two weeks after a first episode of mild ABEP or cholecystitis contributes to patient readmission due to recurrent pancreatitis, resulting in avoidable treatment costs.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biliary Tract Diseases / complications*
  • Biliary Tract Diseases / economics
  • Cholecystectomy* / economics
  • Cholecystitis / complications
  • Female
  • Gallstones / complications
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Pancreatitis / economics
  • Pancreatitis / surgery
  • Pancreatitis / therapy*
  • Patient Readmission / economics
  • Patient Readmission / statistics & numerical data
  • Prospective Studies
  • Recurrence